Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
about
Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase HEmerging microRNA Therapeutic Approaches for Cystic FibrosisOligonucleotides Targeting Telomeres and Telomerase in CancerMelatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction
P2860
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
@en
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
@nl
type
label
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
@en
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
@nl
prefLabel
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
@en
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
@nl
P2860
P921
P356
P1476
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
@en
P2093
Dinh-Duc Nguyen
Suhwan Chang
P2860
P356
10.3390/IJMS19010065
P407
P5008
P577
2017-12-27T00:00:00Z